| The History of the ABO System In 1900, a German scientist, Karl Landsteiner, discovered that blood groups differ from one individual to another. He took blood samples from five associates and himself, allowed them to clot, and then separated the serum from the cells. Landsteiner found that when he mixed the serum and red cells from different individuals, some samples clumped and some didn’t. Our present day classification of the ABO system is based on Landsteiner’s realization that agglutination occurred because of highly reactive antigens present on the red blood cell which corresponded to antibodies present in the serum. Landsteiner isolated and named the red cell antigens “A” and “B” and the corresponding antibodies “Anti-A” and “Anti-B.” If the red cells contained neither antigen, he called these cells “O”, representing zero antigens present. The fourth type of red cells, “AB”, was discovered in 1902 by Von Decastello and Sturli, associates of Landsteiner. “AB” cells contained both A and B antigens on their surface. | View Page |
| Table 2: Testing the Patient Red Cells with Known Antisera (Forward Typing) In routine practice, specially prepared blood grouping sera containing anti-A, anti-B, (and optionally anti-A,B) are used to identify the four types of red cells. These sera will agglutinate cells with the corresponding antigen. This is called forward typing. ABO Blood Group Patient Red Cells Tested with Known Antisera Anti-A Anti-B Anti-A,B A 4+ 0 4+ B 0 4+ 4+ O 0 0 0 AB 4+ 4+ 4+ + = agglutination (graded 1+ to 4+)0 = no agglutination | View Page |
| Table 3: Testing the Serum with Known Red Cells (Reverse Typing) It has been demonstrated that antibodies occur predictably in the sera of all normal adults in association with the ABO antigens. Demonstration of these antibodies is therefore necessary for definitive classification of an individual’s ABO cell type. The individual’s serum is therefore tested against reagent red cells containing known antigens. Patient ABO Blood Group Patient Serum Tested with Known Reagent Cells A Cells B Cells A 0 4+ B 4+ 0 O 4+ 4+ AB 0 0 + = agglutination (graded 1+ to 4+)0 = no agglutination or hemolysis | View Page |
| Why does agglutination (clumping) sometimes occur when red cells from one individual are mixed with serum from another? | View Page |
| Rare Subgroups of A Other rare subgroups of A exist. These comprise less than 1% of the total pool of A genes. Of these rare types, A3 is the most common, but Ax, Aend, and Ael have also been identified. In subgroup A3, the red blood cells characteristically give a “mixed field” agglutination pattern when tested with anti-A and anti-A,B. Small clumps of agglutinated cells are present among large numbers of cells which absorb the antibody to their surface but are not agglutinated by it. | View Page |
| Reaction of Red Cell Subgroups With Known Antisera Subgroup Patient Red Cells Tested with Known Antisera Anti-A1 in Serum? Anti-A Anti-A1 Anti-A,B A1 4+ 4+ 4+ No A2 4+ 0 4+ Yes, 1-2% A3 2+, mixed field 0 2+, mixed field Yes, but % not available + = agglutination (graded 1+ to 4+)0 = no agglutination | View Page |
| Agglutination Reactions Antibodies of the ABO system cause agglutination of saline-suspended red cells at 4°C to 20°C. Heating to 37° weakens the reaction. “Naturally” occurring ABO antibodies may not be strong enough to agglutinate cells without centrifugation. Thus, testing serum for the presence of anti-A or anti-B has classically been performed using the tube system in which serum and cells added to a test tube are centrifuged and then evaluated for agglutination. A slide test has also been performed for forward reactions. Although tube tests are still in wide use, newer systems utilizing other technology such as gel agglutination are becoming more prevalent. The image on this page illustrates agglutination reactions observed with the tube system, from 4+ in the topmost image, to 0 in the lowest image. ABO reactions should be strong. Weak or missing reactions occur, but must be "resolved" before blood products can be released.4+ agglutination: Red blood cell button is a solid agglutinate; clear background.3+ agglutination: Red blood cell button breaks into several large agglutinates; clear background.2+ agglutination: Red blood cell button breaks into many medium-sized agglutinates; clear background; no free red blood cells.1+ agglutination: Red blood cell button breaks into many small clumps barely visible macroscopically; background is turbid; many free red blood cells.Negative: No agglutinated red blood cells present; red cells are observed flowing off the red blood cell button during the process of grading.Other reaction which may occur are the mixed-field reaction, in which mixtures of agglutinated and unagglutinated red blood are present; and hemolysis, in which red cells are hemolyzed by the antibody. Both of these patterns are considered positive reactions. | View Page |
| Forward Typing Forward typing is done using known antisera to detect ABO antigens present on the patient’s red cells. In the tube test, known antisera and patient cells are placed in labeled test tubes, centrifuged, and observed for agglutination. Each manufacturer has specific instructions for its own antisera, detailing the percent of cell suspension, number of drops of cell suspension versus number of drops of antisera, and the rate and length of centrifugation. Though the details differ, the theory behind the tests is the same. | View Page |
| Testing the Red Cells With Known Antisera Patient Red Cells Tested With Known Antisera ABO Antigens Present on Red Cell Anti-A Anti-B Anti-A,B 4+ 0 4+ A 0 4+ 4+ B 0 0 0 Neither A nor B 4+ 4+ 4+ A and B + = agglutination (graded 1+ to 4+) 0 = no agglutination or hemolysis | View Page |
| Reverse Typing Reverse typing refers to the testing of a patient's serum for the presence of ABO antibodies. The patient's serum is mixed with known red cells in a test tube. A specified number of drops of patient serum are placed into each of three properly labeled tubes. A specified number of drops of known A1 cells are added to the A tube, and a specified number of drops of known B cells are added to the B tube. The tubes are mixed by gently shaking, centrifuged, and observed against a well-lit white background for the presence of hemolysis in the supernatant fluid. The cell button is then gently dispersed and inspected for agglutination, again using a well-lit background. Hemolysis or agglutination is a positive reaction. The expected reactions can be seen in the table on the following page. | View Page |
| Testing Patient Serum With Known Reagent Red Cells (Reverse Grouping) Patient Serum Tested With Known Reagent Red Cells Antibodies Present in Serum A1 Cells B Cells 0 4+ Anti-B 4+ 0 Anti-A 4+ 4+ Anti-A and Anti-B 0 0 No ABO antibodies present + = agglutination (graded 1+ to 4+) 0 = no agglutination or hemolysis | View Page |
| Interpretation of ABO Group We can use the forward type together with the reverse type to interpret the ABO group. The expected reaction are as follows: Red Cells Tested With Known Antisera Serum Tested With Known Red Cells Interpretation of ABO Group Anti-A Anti-B Anti-A,B A1 Cells B Cells 4+ 0 4+ 0 4+ A 0 4+ 4+ 4+ 0 B 0 0 0 4+ 4+ O 4+ 4+ 4+ 0 0 AB + = agglutination (graded 1+ to 4+) 0 = no agglutination or hemolysis | View Page |
| Example of an ABO discrepancy The composite image shown on the right illustrates the ABO typing reactions that were obtained for a patient. This particular case illustrates an ABO discrepancy. An ABO discrepancy occurs when the results of forward and reverse typing do not match. The reactions shown are described below in descending order:Patient red cells with reagent anti-A: negative reaction.Patient red cells with reagent anti-B: 4+ agglutination.Patient red cells with reagent anti-D: 4+ agglutination.Patient serum with reagent A1 red cells: negative reaction.Patient serum with reagent B red cells: negative reaction.This patient forward types as a group B, but reverse types as a group AB. (A group B patient should have anti-A. This patient demonstrates neither anti-A nor anti-B, similar to an AB patient). Further workup is necessary to determine the ABO type since the forward and back typing do not match. In this case, incubation at 40 C demonstrated the presence of weakened anti-A. The patient was therefore typed as group B. This case is an example of an ABO discrepancy which was due to a "missing" anti-A antibody. This could be due to old age, severe illness or immunosuppression. Although evaluation of ABO discrepancies is beyond the scope of this course, it is important to note that all ABO discrepancies must be resolved before blood products can be released for transfusion.This patient is Rh (D) positive, as evidenced by the strong agglutination of his cells with reagent anti-D antibody. | View Page |
| Rouleaux Rouleaux formation correlates with an increased concentration of serum monoclonal proteins. Rouleaux may be seen as an artifact in the thicker portions of blood smears. The addition of a drop of saline to the blood smear will serve to disperse any artifactual rouleaux formation. The presence of rouleaux formation or RBC agglutination may result in a falsely decreased electronic red blood count and falsely increased MCV, as these clusters may be read as one cell. | View Page |
| The arrangement of erythrocytes on this peripheral blood smear may be seen in each of the following conditions except: | View Page |
| The arrangement of the erythrocytes in this peripheral smear should be reported out as rouleaux formation. | View Page |
| Guidelines for standard reports In a study on the reporting of red blood cell morphology abnormalities conducted in Ontario, Canada (Hookey L, Dexter D, Lee DH, Laboratory Hematology 7:83-88, 2001), fewer than 50% of 33 participants used the same term to describe the quantitative frequency of peripheral blood abnormalities. Seven blood smears, each containing one of several abnormal erythrocytes-- schistocytes, teardrop cells, acanthocytes, and Howell-Jolly bodies--were evaluated by 32 participants. The participants were asked to document their evaluations from a list of quantitative terms. There was a heterogeneity in the use of terms "rare," "slight," "occasional," "few," "mild", "present," "moderate," "many," and "marked." Choices of terms were subjective without points of reference. Guidelines for establishing standardized qualitative estimations of abnormal erythrocytes in the peripheral smear are presented as follows: 1+ = 2 - 4/Oil Immersion Field (OIF) 2+ = 5 - 7/OIF 3+ = 8 - 10/OIF 4+ = >10/OIF. The terms "few," "moderate," "many," and "marked" may be substituted for the 1+ - 4+ grading system, but only when their specific points of reference are universally understood in tandem with the above guidelines. A comment should be triggered if any erythrocyte abnormalities are seen in numbers >3/OIF including, but not limited to, polychromasia, basophilic stippling, nucleated RBC's, and Howell-Jolly bodies. Rouleaux or RBC agglutination are important findings and must be documented. | View Page |